Latest Knowledge on the Role of Vitamin D in Hypertension
Open Access
- 28 February 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (5) , 4679
Abstract
Hypertension is the third leading cause of the global disease burden, and while populations live longer, adopt more sedentary lifestyles, and become less economically concerned, the prevalence of hypertension is expected to increase. Pathologically elevated blood pressure (BP) is the strongest risk factor for cardiovascular disease (CVD) and related disability, thus making it imperative to treat this disease. Effective standard pharmacological treatments, i.e., diuretics, angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blocker (ARBs), beta-adrenergic receptor blockers (BARBs), and calcium channel blockers (CCBs), are available. Vitamin D (vitD) is known best for its role in bone and mineral homeostasis. Studies with vitamin D receptor (VDR) knockout mice show an increased renin–angiotensin–aldosterone system (RAAS) activity and increased hypertension, suggesting a key role for vitD as a potential antihypertensive agent. Similar studies in humans displayed ambiguous and mixed results. No direct antihypertensive effect was shown, nor a significant impact on the human RAAS. Interestingly, human studies supplementing vitD with other antihypertensive agents reported more promising results. VitD is considered a safe supplement, proposing its great potential as antihypertensive supplement. The aim of this review is to examine the current knowledge about vitD and its role in the treatment of hypertension.Keywords
This publication has 137 references indexed in Scilit:
- Vitamin D3 Therapy Corrects the Tissue Sensitivity to Angiotensin II Akin to the Action of a Converting Enzyme Inhibitor in Obese Hypertensives: An Interventional StudyThe Journal of Clinical Endocrinology & Metabolism, 2012
- Loop Diuretic and Ion-binding Residues Revealed by Scanning Mutagenesis of Transmembrane Helix 3 (TM3) of Na-K-Cl Cotransporter (NKCC1)Journal of Biological Chemistry, 2012
- Role of Vitamin D Supplementation in HypertensionIndian Journal of Clinical Biochemistry, 2010
- Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin–angiotensin systemClinica Chimica Acta, 2010
- The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the “Fountain of Youth” to mediate healthful agingThe Journal of Steroid Biochemistry and Molecular Biology, 2010
- Does Vitamin D Deficiency Cause Hypertension? Current Evidence from Clinical Studies and Potential MechanismsInternational Journal of Endocrinology, 2009
- 25-Hydroxyvitamin D Levels Inversely Associate with Risk for Developing Coronary Artery CalcificationJournal of the American Society of Nephrology, 2009
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin systemJournal of Clinical Investigation, 2002
- Dietary supplementation in elderly patients with fractured neck of the femurThe Lancet, 1990